Quartz

Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical trials for its experimental weight-loss drug, MariTide. And Big Pharma is lobbying for a tax break that would have saved…Read more...

Mar 7, 2025 - 11:06
 0
Wegovy's price cut, Amgen's Ozempic competitor, and Big Pharma's tax cut: Pharma news roundup

Novo Nordisk just cut the price of its weight-loss drug, Wegovy, by more than half for patients who pay without insurance. Amgen (AMGN) announced this week that it has begun two late-stage clinical trials for its experimental weight-loss drug, MariTide. And Big Pharma is lobbying for a tax break that would have saved…

Read more...

Read More

Tags:

Previous Article

Amazon's AI dubs, Google's Gemini Live update, and TSMC's $100 billion: AI news ...

Next Article

Target's price hikes, Walmart's China strategy, and Starbucks' tough love: Retai...

Related Posts

Amazon plans an AI spending spree — joining Google, Meta, and Microsoft

Amazon plans an AI spending spree — joining Google, Met...

Feb 9, 2025  0

Billy McFarland "really hopes" Fyre Fest 2.0 can book musicians

Billy McFarland "really hopes" Fyre Fest 2.0 can book m...

Feb 24, 2025  0

Stocks are treading water as the Fed wants more progress on inflation before cutting interest rates

Stocks are treading water as the Fed wants more progres...

Feb 19, 2025  0